300mg

Paclitaxel AqVida

Paclitaxel AqVida 300mg/50ml Concentrate For Solut

Paclitaxel

Himmel Pharmaceuticals Private Limited

Drug Identity

Active Ingredient
Paclitaxel
Drug Class
Antineoplastics
ATC Code
L01CD01
Status
Essential Medicine

How It Works

The concentrate must be diluted to a final Paclitaxel cone of 0.3 to 1.2 mg/ml in D5W, NS, D5NS. Administration over 3 hours is often recommended.

How to Take It

Dosage information not available for this product.

Safety Alerts

Acute porphyrias, Neutrophils less than 1
5x109 per litre, severe hepatic impairment

Important Warnings

Patients aged over 75 years with metastatic adenocarcinoma of the pancreas
Monitor blood counts, Cardiac conduction abnormalities, peripheral neuropathy, renal or hepatic failure
Ensure resuscitation equipment available

Side Effects

ArrhythmiaarthralgiafebrileneutropeniaGI disordersmyalgiaperipheral neuropathysensory neuropathytachycardiaalopeciahypotensionbone marrow suppressionbradycardiacardiac conduction defectsextravasationhypersensitivity reactions

Pregnancy & Lactation

Pregnancy
Contraindication in pregnancy
Lactation
Contraindicated. Discontinue breast-feeding

Price Intelligence

Rs 39,460.98
DRAP approved maximum price · per unit · approved 29 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper unitRs 39,460.98

Should you consider an alternative?

Other options containing Paclitaxel, and what they are not.

Identical active ingredient at the same strength. Cheapest per unit first.

Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.

For pharma professionalsCompany, market and opportunity intelligence

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.